SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001104659-22-069393
Filing Date
2022-06-08
Accepted
2022-06-08 17:24:01
Documents
6

Document Format Files

Seq Description Document Type Size
1 POS AM tm2217745-1_posam.htm POS AM 708413
2 EXHIBIT 23.1 tm2217745d2_ex23-1.htm EX-23.1 3100
3 EX-FILING FEES tm2217745d2_ex-filingfees.htm EX-FILING FEES 40169
4 GRAPHIC lg_nrx-4clr.jpg GRAPHIC 44547
5 GRAPHIC tm2217745d2_ex23-1img001.jpg GRAPHIC 3670
6 GRAPHIC tm2217745d2_ex23-1img002.jpg GRAPHIC 2935
  Complete submission text file 0001104659-22-069393.txt   823713
Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-264201 | Film No.: 221004252
SIC: 2834 Pharmaceutical Preparations